Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
William Nuerge Insider Profile
4 Followers
William Nuerge, Director at Supernus Pharmaceuticals, holds 47.50K shares in Supernus Pharmaceuticals (Ticker: SUPN). Most recently, William Nuerge Bought $15,000 shares of Supernus Pharmaceuticals on May 07, 2012 for an estimated value of 75.00K.
William Nuerge has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that William Nuerge holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 07, 2012 - May 07, 2013
Return:-13.30%
The most profitable trade made by William Nuerge
William Nuerge's Trading History
List of latest transactions for each holding click on a transaction to see William Nuerge's performance on stock
You May Also Like
William Nuerge insider profile FAQ
What is the percentage of profitable transactions made by William Nuerge?
The percentage of profitable transactions made by William Nuerge is ―.
What is the average return per transaction made by William Nuerge?
The average return per transaction made by William Nuerge is ―.
What stocks does William Nuerge hold?
William Nuerge holds: SUPN stocks.
What was William Nuerge’s latest transaction?
William Nuerge latest transaction was an Informative Buy of $75.00K.
What was William Nuerge's most profitable transaction?
William Nuerge’s most profitable transaction was an Informative Buy of SUPN stock on May 7, 2012. The return on the trade was -13.30%.
What is William Nuerge's role in Supernus Pharmaceuticals?
William Nuerge's role in Supernus Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.